Wenge Lu

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Cyclacel Pharmaceuticals (United Kingdom)14.2%
• Cedars-Sinai Medical Center9.3%
• Moffitt Cancer Center8.6%
• Molecular Oncology (United States)8.1%
• University of Birmingham6.8%
• University of Alabama at Birmingham6.6%
• Other46.5%

Fields

• Medicine58.1%
• Biochemistry, Genetics and Molecular Biology32.8%
• Immunology and Microbiology3.5%
• Environmental Science1.7%
• Neuroscience1.7%
• Chemistry0.9%
• Other1.3%

Topics

• Cancer-related Molecular Pathways31%
• Ubiquitin and proteasome pathways11.2%
• Cancer Research and Treatments6.9%
• Pituitary Gland Disorders and Treatments6.5%
• Microtubule and mitosis dynamics6.2%
• Epigenetics and DNA Methylation6%
• Other32.3%